Melatonin 5 mg Use in Adults
Melatonin 5 mg is not recommended as a treatment for general insomnia in adults, though it may be considered for specific circadian rhythm disorders such as Delayed Sleep-Wake Phase Disorder (DSWPD). 1, 2
General Recommendations for Insomnia
- The American Academy of Sleep Medicine (AASM) explicitly suggests that clinicians not use melatonin as a treatment for sleep onset or maintenance insomnia in adults 1
- This recommendation is based on trials of 2 mg doses of melatonin, which showed insufficient evidence of clinical benefit 1
- Cognitive behavioral therapy for insomnia (CBT-I) is the preferred first-line approach for both sleep onset and maintenance insomnia 2
Specific Uses of Melatonin 5 mg in Adults
- For adults with Delayed Sleep-Wake Phase Disorder (DSWPD), 5 mg melatonin timed between 19:00-21:00 for 28 days has shown some benefit 1
- In studies of adults with DSWPD, 5 mg melatonin decreased sleep latency by 37-43 minutes and increased total sleep time by 41-56 minutes 1
- The AASM suggests melatonin for DSWPD with a "WEAK FOR" recommendation, indicating benefits likely outweigh harms but many patients might choose not to use this treatment 1
Dosing Considerations
- Clinical studies have used various doses ranging from 0.5 mg to 10 mg in adults 3, 4
- For general adult use, effective doses typically range from 1-5 mg 3
- For older adults (>55 years), doses between 1-6 mg appear effective for improving sleep 4, 5
- A recent study found that 5 mg significantly increased sleep efficiency during both biological day and night in older adults, while 0.3 mg only improved daytime sleep 5
Safety Considerations
- Short-term side effects of melatonin at doses of 5 mg or less are generally mild 3, 6
- Common side effects include daytime sleepiness 6
- The benefits/harms ratio remains uncertain, as long-term safety data (>6 months) are lacking 6
- Potential concerns include:
Clinical Decision Algorithm
For general insomnia in adults:
For adults with DSWPD:
For older adults (>55 years) with sleep difficulties:
Common Pitfalls
- Using melatonin as first-line therapy for general insomnia when evidence doesn't support this practice 1, 2
- Failing to distinguish between general insomnia and circadian rhythm disorders, where melatonin may have different efficacy 1
- Not considering timing of administration, which is critical for effectiveness in circadian disorders 1
- Assuming that higher doses are always more effective - some studies show efficacy at lower doses with fewer side effects 4, 7